{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:39:39Z","timestamp":1789839579956,"version":"4.0.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-NS047592"],"award-info":[{"award-number":["R01-NS047592"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01-NS059560"],"award-info":[{"award-number":["P01-NS059560"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01- EY025500"],"award-info":[{"award-number":["U01- EY025500"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG1701-26617"],"award-info":[{"award-number":["RG1701-26617"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["FG-1507-05315"],"award-info":[{"award-number":["FG-1507-05315"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["SCUT 2018MS23"],"award-info":[{"award-number":["SCUT 2018MS23"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Optic neuritis is a frequent first symptom of multiple sclerosis (MS) for which corticosteroids are a widely employed treatment option. The Optic Neuritis Treatment Trial (ONTT) reported that corticosteroid treatment does not improve long-term visual acuity, although the evolution of underlying pathologies is unclear. In this study, we employed non-invasive diffusion basis spectrum imaging (DBSI)-derived fiber volume to quantify 11% axonal loss 2 months after corticosteroid treatment (vs. baseline) in experimental autoimmune encephalomyelitis mouse optic nerves affected by optic neuritis. Longitudinal DBSI was performed at baseline (before immunization), after a 2-week corticosteroid treatment period, and 1 and 2 months after treatment, followed by histological validation of neuropathology. Pathological metrics employed to assess the optic nerve revealed axonal protection and anti-inflammatory effects of dexamethasone treatment that were transient. Two months after treatment, axonal injury and loss were indistinguishable between PBS- and dexamethasone-treated optic nerves, similar to results of the human ONTT. Our findings in mice further support that corticosteroid treatment alone is not sufficient to prevent eventual axonal loss in ON, and strongly support the potential of DBSI as an <jats:italic>in vivo<\/jats:italic> imaging outcome measure to assess optic nerve pathology.<\/jats:p>","DOI":"10.3389\/fnins.2020.592063","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T05:47:38Z","timestamp":1611294458000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Diffusion Basis Spectrum Imaging Detects Axonal Loss After Transient Dexamethasone Treatment in Optic Neuritis Mice"],"prefix":"10.3389","volume":"14","author":[{"given":"Tsen-Hsuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wallendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne H.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Kwei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/mrm.10491","article-title":"Anisotropic noise propagation in diffusion tensor MRI sampling schemes.","volume":"49","author":"Batchelor","year":"2003","journal-title":"Magn. Reson. Med."},{"key":"B2","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199312093292403","article-title":"The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. the optic neuritis study group.","volume":"329","author":"Beck","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/jnnp-2014-308185","article-title":"Re-evaluating the treatment of acute optic neuritis.","volume":"86","author":"Bennett","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/1531-8249(200012)48:6<893::aid-ana10>3.0.co;2-b","article-title":"Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.","volume":"48","author":"Bjartmar","year":"2000","journal-title":"Ann. Neurol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.35.3.365-b","article-title":"Double embedding in agar\/paraffin wax as an aid to orientation of mucosal biopsies.","volume":"35","author":"Blewitt","year":"1982","journal-title":"J. Clin. Pathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.7326\/0003-4819-119-12-199312150-00007","article-title":"Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates.","volume":"119","author":"Boumpas","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/00004836-200110000-00006","article-title":"Side effects of corticosteroid therapy","volume":"33","author":"Buchman","year":"2001","journal-title":"J. Clin. Gastroenterol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/wco.0b013e328354f63f","article-title":"MRI in multiple sclerosis: a review of the current literature.","volume":"25","author":"Ceccarelli","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.neuroimage.2014.06.064","article-title":"Quantifying white matter tract diffusion parameters in the presence of increased eased extra-fiber cellularity and vasogenic edema.","volume":"101","author":"Chiang","year":"2014","journal-title":"Neuroimage"},{"key":"B10","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography.","volume":"59","author":"Costello","year":"","journal-title":"Ann. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography.","volume":"59","author":"Costello","year":"","journal-title":"Ann. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights.","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jnnp.67.6.710","article-title":"Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup?","volume":"67","author":"Davie","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"6993","DOI":"10.1523\/jneurosci.23-18-06993.2003","article-title":"Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway.","volume":"23","author":"Diem","year":"2003","journal-title":"J. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1365-3083.2010.02451.x","article-title":"Specific and strain-independent effects of dexamethasone in the prevention and treatment of experimental autoimmune encephalomyelitis in rodents.","volume":"72","author":"Donia","year":"2010","journal-title":"Scand. J. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0197-4580(81)90039-7","article-title":"Life-span change in visually evoked potentials at central scalp.","volume":"2","author":"Dustman","year":"1981","journal-title":"Neurobiol. Aging"},{"key":"B17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.12998\/wjcc.v3.i7.545","article-title":"Treatment strategies for multiple sclerosis: when to start, when to change, when to stop?","volume":"3","author":"Gajofatto","year":"2015","journal-title":"World J. Clin. Cases"},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001430.pub3","article-title":"Corticosteroids for treating optic neuritis.","volume":"4","author":"Gal","year":"2012","journal-title":"Cochrane Database. Syst. Rev."},{"key":"B19","article-title":"Corticosteroids for treating optic neuritis.","volume":"8","author":"Gal","year":"2015","journal-title":"Cochrane Database. Syst. Rev."},{"key":"B20","first-page":"1165","article-title":"Multiple sclerosis: the role of MR imaging.","volume":"27","author":"Ge","year":"2006","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.schres.2015.05.007","article-title":"Specificity and sensitivity of visual evoked potentials in the diagnosis of schizophrenia: rethinking VEPs.","volume":"166","author":"Gonzalez-Hernandez","year":"2015","journal-title":"Schizophr. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1177\/1352458516675039","article-title":"Importance of early treatment initiation in the clinical course of multiple sclerosis","volume":"23","author":"Kavaliunas","year":"2017","journal-title":"Mult. Scler."},{"key":"B23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9440(10)64537-3","article-title":"Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.","volume":"157","author":"Kornek","year":"2000","journal-title":"Am. J. Pathol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1167\/iovs.08-2683","article-title":"Retrobulbar optic nerve diameter measured by high-speed magnetic resonance imaging as a biomarker for axonal loss in glaucomatous optic atrophy.","volume":"50","author":"Lagreze","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1210\/mend-5-12-1903","article-title":"Dexamethasone increases potassium channel messenger RNA and activity in clonal pituitary cells.","volume":"5","author":"Levitan","year":"1991","journal-title":"Mol. Endocrinol."},{"key":"B26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archfacial.2010.98","article-title":"Effects of corticosteroids on functional recovery and neuron survival after facial nerve injury in mice.","volume":"13","author":"Lieberman","year":"2011","journal-title":"Arch. Facial. Plast. Surg."},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-017-0852-3","article-title":"Diffusion MRI quantifies early axonal loss in the presence of nerve swelling.","volume":"14","author":"Lin","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.neuroimage.2014.06.009","article-title":"Axonal transport rate decreased at the onset of optic neuritis in EAE mice.","author":"Lin","year":"","journal-title":"Neuroimage"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2014.02.007","article-title":"Diffusion fMRI detects white-matter dysfunction in mice with acute optic neuritis.","volume":"67","author":"Lin","year":"","journal-title":"Neurobiol. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1089\/neu.2018.6016","article-title":"Noninvasive quantification of axonal loss in the presence of tissue swelling in traumatic spinal cord injury mice","volume":"36","author":"Lin","year":"2019","journal-title":"J. Neurotrauma."},{"key":"B31","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ins.2011.10.011","article-title":"Segmentation of multiple sclerosis lesions in brain MRI: a review of automated approaches.","volume":"186","author":"Llado","year":"2012","journal-title":"Inform. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/brain\/awg061","article-title":"Axonal damage: a key predictor of outcome in human CNS diseases.","volume":"126","author":"Medana","year":"2003","journal-title":"Brain"},{"key":"B33","first-page":"623","article-title":"Diminution of cortical visually evoked potentials during the following eye-movement in the cat.","volume":"41","author":"Michalski","year":"1981","journal-title":"Acta Neurobiol. Exp."},{"key":"B34","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.expneurol.2014.08.009","article-title":"Dexamethasone enhances necrosis-like neuronal death in ischemic rat hippocampus involving mu-calpain activation.","volume":"261","author":"Muller","year":"2014","journal-title":"Exp. Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1600-0404.2009.01213.x","article-title":"Corticosteroids in the treatment of multiple sclerosis.","volume":"189","author":"Myhr","year":"2009","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"B36","first-page":"s321","article-title":"Impact of diagnosis and early treatment on the course of multiple sclerosis","volume":"19","author":"Noyes","year":"2013","journal-title":"Am. J. Manag. Care"},{"key":"B37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2169\/internalmedicine1962.26.212","article-title":"High-dose intravenous corticosteroids in the treatment of multiple sclerosis","volume":"26","author":"Ohno","year":"1987","journal-title":"Jpn. J. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1549-8719.2000.tb00117.x","article-title":"The microcirculation and inflammation: site of action for glucocorticoids.","volume":"7","author":"Perretti","year":"2000","journal-title":"Microcirculation"},{"key":"B39","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ana.24487","article-title":"Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study.","volume":"78","author":"Saidha","year":"2015","journal-title":"Ann. Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ana.20202","article-title":"Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain.","volume":"56","author":"Schmierer","year":"2004","journal-title":"Ann. Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.neuroimage.2003.07.005","article-title":"Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia.","volume":"20","author":"Song","year":"2003","journal-title":"Neuroimage"},{"key":"B42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.neuroimage.2012.10.021","article-title":"White-matter diffusion fMRI of mouse optic nerve.","volume":"65","author":"Spees","year":"2013","journal-title":"Neuroimage"},{"key":"B43","article-title":"Using absorption-mode images to improve in vivo DTI quality.","volume":"18","author":"Tu","year":"2010","journal-title":"Proc. Intl. Soc. Mag. Reson. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.joms.2011.09.045","article-title":"Traumatic optic neuropathy after maxillofacial trauma: a review of 8 cases.","volume":"70","author":"Urolagin","year":"2012","journal-title":"J. Oral Maxillofac. Surg."},{"key":"B45","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/0042-6989(81)90197-8","article-title":"Peripheral contrast reversal inhibits visually evoked potentials in the fovea.","volume":"21","author":"Valberg","year":"1981","journal-title":"Vis. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1136\/jnnp.2005.064816","article-title":"Axon loss is an important determinant of weakness in multifocal motor neuropathy.","volume":"77","author":"Van Asseldonk","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/1531-8249(199911)46:5<747::aid-ana10>3.0.co;2-4","article-title":"Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability.","volume":"46","author":"van Waesberghe","year":"1999","journal-title":"Ann. Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/nbm.3129","article-title":"Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice.","volume":"27","author":"Wang","year":"2014","journal-title":"NMR Biomed."},{"key":"B49","first-page":"625","article-title":"Transnasal endoscopic optic canal decompression for traumatic optic neuropathy without light reception.","volume":"42","author":"Wang","year":"2007","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/brain\/awv046","article-title":"Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.","volume":"138","author":"Wang","year":"2015","journal-title":"Brain"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1093\/brain\/awr307","article-title":"Quantification of increased cellularity during inflammatory demyelination.","volume":"134","author":"Wang","year":"","journal-title":"Brain"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1093\/brain\/awr307","article-title":"Quantification of increased cellularity during inflammatory demyelination.","volume":"134","author":"Wang","year":"","journal-title":"Brain J. Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/jnen\/61.1.23","article-title":"Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.","volume":"61","author":"Wujek","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"8434","DOI":"10.4049\/jimmunol.180.12.8434","article-title":"Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis.","volume":"180","author":"Wust","year":"2008","journal-title":"J. Immunol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2020.592063\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T05:47:43Z","timestamp":1611294463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2020.592063\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":54,"alternative-id":["10.3389\/fnins.2020.592063"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2020.592063","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"article-number":"592063"}}